CompletedNot Applicable

Improving Surgical/Medical Oncology Collaboration for Breast Cancer Treatment Planning: Pilot Testing the Impact of Continuing Education and Patient Care Planning

United States25 participantsStarted 2017-05-18

Plain-language summary

This study will explore provider's screening and management practices for eligibility for neoadjuvant therapy from baseline to following the project intervention (use of a novel existing technology, the Carevive Care Planning System at the point of care plus provider continuing medical education.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 1\) 18 years of age and older * 2\) Patients must have a diagnosis of breast cancer for which they must not have received or been scheduled for primary breast surgery at time of project intervention, and must be eligible for surgical resection (i.e. Stage I-III). Exclusion Criteria: * Any patient who cannot understand written or spoken English

What they're measuring

Rates of provider self-report and actual percent of eligible patients referred to medical oncology for discussion of neoadjuvant therapy.

Timeframe: Year 1

Rates of actual prescription of neoadjuvant therapy to eligible patients

Timeframe: Year 1

Trial details

NCT IDNCT03161600

SponsorCarevive Systems, Inc.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2018-12-31

View on ClinicalTrials.gov More Breast Cancer trials